APA (7th ed.) Citation

AA, A., AM, A., HM, B., JS, A., RA, S., M, M., . . . H, A. (2023). Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: Systematic review. Frontiers in medicine, 10, 1217156. https://doi.org/10.3389/fmed.2023.1217156

Chicago Style (17th ed.) Citation

AA, Alqarni, et al. "Inhaled Therapies Targeting Prostacyclin Pathway in Pulmonary Hypertension Due to COPD: Systematic Review." Frontiers in Medicine 10 (2023): 1217156. https://doi.org/10.3389/fmed.2023.1217156.

MLA (9th ed.) Citation

AA, Alqarni, et al. "Inhaled Therapies Targeting Prostacyclin Pathway in Pulmonary Hypertension Due to COPD: Systematic Review." Frontiers in Medicine, vol. 10, 2023, p. 1217156, https://doi.org/10.3389/fmed.2023.1217156.